Hayden Royal, LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hayden Royal, LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$101,000
-5.6%
16,9000.0%0.06%
-8.2%
Q1 2021$107,000
-6.1%
16,900
-14.1%
0.06%0.0%
Q3 2020$114,000
-99.9%
19,675
-2.3%
0.06%
-25.6%
Q2 2020$145,159,000
+47.6%
20,133
-4.2%
0.08%
+41.4%
Q1 2020$98,317,000
+79187.9%
21,008
+16.2%
0.06%
-46.8%
Q3 2019$124,000
+11.7%
18,078
+33.1%
0.11%
-7.6%
Q2 2019$111,00013,5780.12%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 250,000$2,005,0005.90%
Sio Capital Management, LLC 731,453$5,866,0001.40%
KNOTT DAVID M 218,102$1,749,0000.71%
ArrowMark Colorado Holdings LLC 8,813,578$70,685,0000.63%
DAFNA Capital Management LLC 209,200$1,678,0000.58%
Park West Asset Management LLC 1,545,075$12,391,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 590,000$4,732,0000.39%
Cornerstone Capital, Inc. 245,796$1,971,0000.28%
Ikarian Capital, LLC 150,000$1,203,0000.20%
Ikarian Capital, LLC 150,000$1,203,0000.20%
View complete list of VIKING THERAPEUTICS INC shareholders